M. Dreyling Et Al. , "Phosphatidylinositol 3-Kinase Inhibition by Copanlisib in Relapsed or Refractory Indolent Lymphoma," JOURNAL OF CLINICAL ONCOLOGY , vol.35, no.35, pp.3898-3909, 2017
Dreyling, M. Et Al. 2017. Phosphatidylinositol 3-Kinase Inhibition by Copanlisib in Relapsed or Refractory Indolent Lymphoma. JOURNAL OF CLINICAL ONCOLOGY , vol.35, no.35 , 3898-3909.
Dreyling, M., Santoro, A., Mollica, L., Leppa, S., Follows, G. A., Lenz, G., ... Kim, W. S.(2017). Phosphatidylinositol 3-Kinase Inhibition by Copanlisib in Relapsed or Refractory Indolent Lymphoma. JOURNAL OF CLINICAL ONCOLOGY , vol.35, no.35, 3898-3909.
Dreyling, Martin Et Al. "Phosphatidylinositol 3-Kinase Inhibition by Copanlisib in Relapsed or Refractory Indolent Lymphoma," JOURNAL OF CLINICAL ONCOLOGY , vol.35, no.35, 3898-3909, 2017
Dreyling, Martin Et Al. "Phosphatidylinositol 3-Kinase Inhibition by Copanlisib in Relapsed or Refractory Indolent Lymphoma." JOURNAL OF CLINICAL ONCOLOGY , vol.35, no.35, pp.3898-3909, 2017
Dreyling, M. Et Al. (2017) . "Phosphatidylinositol 3-Kinase Inhibition by Copanlisib in Relapsed or Refractory Indolent Lymphoma." JOURNAL OF CLINICAL ONCOLOGY , vol.35, no.35, pp.3898-3909.
@article{article, author={Martin Dreyling Et Al. }, title={Phosphatidylinositol 3-Kinase Inhibition by Copanlisib in Relapsed or Refractory Indolent Lymphoma}, journal={JOURNAL OF CLINICAL ONCOLOGY}, year=2017, pages={3898-3909} }